Question: A 47-year-old gender nonbinary individual is clinically diagnosed with secondary syphilis and treated with benzathine penicillin G 2.4 million units intramuscular (IM) in a single dose. Their lab test results return with a positive syphilis enzyme immunoassay (EIA) and a positive Rapid Plasma Reagin (RPR) at a titer of 1:256. Their HIV-1/2 antigen-antibody test is negative. At a follow-up visit in 6 months, no new symptoms have developed and RPR testing reveals a titer of 1:32. What would you recommend as the next course of action regarding management of syphilis for this individual? Treat with a single dose of intramuscular benzathine penicillin G 2.4 million units Treat with a total of benzathine penicillin administered as 3 intramuscular doses of 2.4 million units at 1-week intervals Perform a lumbar puncture and cerebrospinal fluid analysis and treat based on these findings No further treatment is necessary at this time, but continue monitoring